Properties (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Patent
|
| gptkbp:covers |
Methods of Treatment
|
| gptkbp:hasAssignee |
gptkb:K26,_Inc.
|
| gptkbp:hasClaim |
20
|
| gptkbp:hasFieldOfUse |
Medical
|
| gptkbp:hasFilingDate |
February 10, 2004
|
| gptkbp:hasInventor |
gptkb:John_Doe
|
| gptkbp:hasLegalStatus |
Active
|
| gptkbp:hasPatentNumber |
6,789,799
|
| gptkbp:hasPriorityDate |
February 10, 2003
|
| gptkbp:hasPublications |
September 14, 2004
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,799 K26 Family
|
| gptkbp:includes |
Active Ingredient
|
| gptkbp:isCitedBy |
gptkb:US_7,123,456
|
| gptkbp:isExaminedBy |
gptkb:USPTO
Yes |
| gptkbp:isFiledIn |
gptkb:United_States
|
| gptkbp:isFiledUnder |
35 U.S.C. § 111(a)
|
| gptkbp:isGranted |
Yes
|
| gptkbp:isNotableFor |
February 10, 2024
|
| gptkbp:isPartOf |
gptkb:K26_Patent_Family
|
| gptkbp:isPublishedIn |
USPTO Database
|
| gptkbp:isRelatedTo |
Drug Development
|
| gptkbp:isSubjectTo |
Maintenance Fees
|
| gptkbp:relatedTo |
Pharmaceutical Composition
|